14 - 20 May 2016
These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts.
Neurological Alliance unhappy with government response to report
The Neurological Alliance is disappointed with the government's response to the Public Accounts Committee's report criticising neurology services in England, saying, "Once again, the Government has sent a message that the needs of people with neurological conditions are simply not important enough to focus on."
Source: Neurological Alliance
Relapses and disease modifying drugs
Research into the effects of relapses found that relapses that happen whilst someone is receiving a disease modifying drug are an indicator of a faster build up in disability. People who remained stable whilst on disease modifying drug treatment had on average a one point lower EDSS score than would be expected in someone not on treatment
Source: News Medical
MS Trust link: MS Decisions - a guide to disease modifying drugs
Vitamin D levels in Orkney
Viruses and onset of MS
A study has found that the level in the blood of immune cells targeting the brain and spinal cord correlates with the immune response to Epstein-Barr virus (EBV) and cytomegalovirus (CMV). Suggests some viral link to MS, though what this is is not yet clear
Source: MS News Today
MS Trust link: Epstein Barr virus
Pregabalin and birth defects
A study of women who took pregabalin during a pregnancy found they were more likely to experience major birth defects than women in a control group (6% v 2%). None of the women in the study had MS, though pregabalin is used in MS to treat pain. It is already advised that pregnant women should not take pregabalin
MS Trust link: Pregabalin
Inequalities in multiple sclerosis care
A survey by the MS Trust has highlighted inconsistencies in access to MS specialist health professionals around the country.
Source: Clacton Gazette